REGN Operating Cash Flow
Regeneron Pharmaceuticals · Operating Cash Flow
REGN Operating Cash Flow
Latest reported$4.44Bperiod ending
REGN Operating Cash Flow (-$6.80M → $4.44B)
Annual operating cash flow
High-resolution chart · PNG
REGN operating cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 4,978,900,000 | |
| 4,420,500,000 | |
| 4,594,000,000 | |
| 5,014,900,000 | |
| 7,081,300,000 | |
| 2,618,100,000 | |
| 2,430,000,000 | |
| 2,195,100,000 | |
| 1,307,100,000 | |
| 1,485,900,000 | |
| 1,330,780,000 | |
| 752,435,000 | |
| 588,596,000 | |
| -74,615,000 | |
| -141,682,000 | |
| 96,344,000 | |
| -72,230,000 | |
| -89,086,000 | |
| 27,372,000 | |
| 23,075,000 | |
| -30,296,000 | |
| -16,909,000 | |
| -6,133,000 | |
| -110,523,000 | |
| -57,320,000 | |
| -27,910,000 | |
| -13,800,000 | |
| -10,200,000 | |
| -6,100,000 | |
| -20,300,000 | |
| -18,200,000 | |
| -20,500,000 | |
| -30,100,000 | |
| -17,200,000 | |
| -6,800,000 |